Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - Its relevance for child and adolescent psychiatrists;Entzugsdelir nach missbrauch von GHB-(Gamma-Hydroxybutyrat) und seiner vorstufen - Grundlagen und bedeutung für die kinder- und jugendpsychiatrie

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 37, Issue 5, 2009, Pages 413-420

  Zepf, Florian D ^a,b,c   Holtmann, Martin ^c,d   Duketis, Eftichia ^c   Maier, Joachim ^c   Radeloff, Daniel ^c   Schirman, Shella ^c   Wagner, Angela ^c   Poustka, Fritz ^c   Wöckel, Lars ^a,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b JARA Translational Brain Medicine   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

1,4 butandiole (1,4 bd); Gamma butyrolactone (gbl); Gamma hydroxybutyrate (ghb); Liquid ecstasy; Withdrawal syndrome

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; GAMMA BUTYROLACTONE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OXYBATE SODIUM; PHENOBARBITAL;

ACUTE KIDNEY FAILURE; CHILD DEATH; CHILD PSYCHIATRY; DRUG ABUSE; DRUG MEGADOSE; DYSTONIA; ECG ABNORMALITY; HUMAN; PSYCHIATRIST; REVIEW; RHABDOMYOLYSIS; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

4-BUTYROLACTONE; ACUTE DISEASE; ADOLESCENT; ANESTHETICS, INTRAVENOUS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BUTYLENE GLYCOLS; CHILD; DELUSIONS; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; HUMANS; INTENSIVE CARE; PSYCHOSES, SUBSTANCE-INDUCED; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 70249085542     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917.37.5.413     Document Type: Review

References (43)

1. Andresen, H., Stimpfl, T., Sprys, N., Schnitgerhans, T. & Müller A. (2008). Liquid Ecstasy - ein relevantes Drogenproblem. Deutsches Ärzteblatt, 105, 599-603.
2. Bania, T. C., Ashar, T., Press, G. & Carey, P. M. (2003). Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model. Academic Emergency Medicine, 10, 697-704. (Pubitemid 36835064)
3. Bhattacharya, I. & Boje, K. M. (2004). GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics, 311, 92-98. (Pubitemid 39287787)
4. Bialer, P. A. (2002). Designer drugs in the general hospital. Psychiatric Clinics of North America, 25, 231-243.
5. Bowles, T. M., Sommi, R. W. & Amiri, M. (2001). Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal. Pharmacotherapy, 21, 254-257. (Pubitemid 32119203)
6. Carrai, M. A., Quang, L. S., Atzeri, S., Lobina, C., Maccioni, P., Orru, A. et al. (2005). Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats. Brain Research Protocols, 15, 75-78. (Pubitemid 40828887)
7. Catalano, M. C., Glass, J. M., Catalano, G., Burrows, S. L., Lynn, W. A. & Weitzner B. S. (2001). Gamma butyrolactone (GBL) withdrawal syndromes. Psychosomatics, 42, 83-88. (Pubitemid 32062222)
8. Chin, R. L. (2001). A case of severe withdrawal from gamma- hydroxybutyrate. Annals of Emergency Medicine, 37, 561-562.
9. Craig, K., Gomez, H. F., McManus, J. L. & Bania, T. C. (2000). Severe gamma-hydroxybutyrate withdrawal: A case report and literature review. Journal of Emergency Medicine, 18, 65-70. (Pubitemid 30029188)
10. Doyon, S. (2001). The many faces of ecstasy. Current Opinion in Pediatrics, 13, 170-176.
11. Dyer, J. E., Roth, B. & Hyma, B. A. (2001). Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine, 37, 147-153.
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2006). Annual Report 2006. Verfügbar unter: http://ar2006.emcdda.europa.eu/de/ page022-de.html [06.07.2009].
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2008). EMCDDA thematic papers - GHB and ist precursor GBL: An emerging trend case study. Verfügbar unter: http://www.emcdda.europa.eu/html.cfm/index7079EN. html [06.07.2009].
14. Galloway, G. P., Frederick, S. L., Staggers, F. E. Jr., Gonzalez, M., Stalcup S. A. & Smith D. E. (1997). Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence. Addiction, 92, 89-96.
15. Garcia, F. B., Pedraza, C. & Navarro, J. F. (2006). Update on gamma-hydroxybutyric acid. Revista de Neurología, 43, 39-48.
16. Glisson, J. K. & Norton, J. (2002). Self-medication with gammahydroxybutyrate to reduce alcohol intake. Southern Medical Journal, 95, 926-928.
17. Gonzalez, A. & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology, 19, 195-204. (Pubitemid 40577225)
18. Goodwin, A. K., Griffiths, R. R., Brown, P. R., Froestl, W., Jakobs, C., Gibson, K. M. et al. (2006). Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology (Berl), 189, 71-82. (Pubitemid 44607261)
19. Griffiths, R. R. & Johnson, M. W. (2005). Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. Journal of Clinical Psychiatry, 66, 31-41.
20. Hernandez, M., McDaniel, C. H., Costanza, C. D. &, Hernandez, O. J. (1998). GHB-induced delirium: A case report and review of the literature on gamma hydroxybutyric acid. American Journal of Drug Abuse, 24, 179-183.
21. Kam, P. C. A. & Yoong, F. F. Y. (1998). Gamma-hydroxybutyric acids: An emerging recreational drug. Anaesthesia, 53, 1195-1198.
22. Laborit, H. (1964). Sodium 4-hydroxybutyrate. International Journal of Neuropharmacology, 3, 433-452.
23. Li, J., Stokes, S. A. & Woeckener, A. (1998). A tale of novel intoxication: A review of the effects of gamma-hydroxybutyric acid with recommendations for management. Annals of Emergency Medicine, 31, 729-736. (Pubitemid 28252629)
24. Mahr, G., Bishop, G. L. & Orringer, D. J. (2001). Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse. Psychosomatics, 42, 439-440. (Pubitemid 33032119)
25. Maitre, M., Humbert, J. P., Kemmel, V., Aunis, D. & Andriamampandry, C. (2005). A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse. International Journal of Medical Sciences (Paris), 21, 284-289. (Pubitemid 40396208)
26. Mason, P. E. & Kerns, W. P. (2002). Gamma hydroxybutyric acid (GHB) intoxication. Academic Emergency Medicine, 9, 730-739. (Pubitemid 34747263)
27. McDonough, M., Kennedy, N., Glasper, A. & Bearn J. (2004). Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review. Drug and Alcohol Dependence, 75, 3-9. (Pubitemid 38844572)
28. Meyer, S., Kleinschmidt, S., Gottschling, S., Gortner, L. & Strittmatter, M. (2005). Gamma-hydroxy butyric acid: Neurotransmitter, sedative and party drug. Wiener Medizinische Wochenschrift, 155, 315-322. (Pubitemid 41098087)
29. Migliani, J. S., Kim, K. Y & Chahil, R. (2000). Gamma-hydroxy butyrate withdrawal delirium: A case report. General Hospital Psychiatry, 22, 213-215. (Pubitemid 30394717)
30. Nimmerrichter, A. A., Walter, H., Gutierrez-Lobos, K.E. & Lesch, O. M. (2002). Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol, 37, 67-73. (Pubitemid 34173312)
31. Palmer, R. B. (2004). Gamma-butyrolactone and 1,4-butanediol: Abused analogues of gamma-hydroxybutyrate. Toxicology Review, 23, 21-31.
32. Parnefjord, R. (2005). Das Drogentaschenbuch (4., unveränderte Auflage). Stuttgart: Thieme Verlag.
33. Quang, L. S., Colombo, G., Lobina, C., Maccioni, P., Orru, A., Gessa, G. L. et al. (2006). Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Annals of the New York Academy of Sciences, 1074, 545-548. (Pubitemid 44532859)
34. Rosenberg, M. H., Deerfield, L. J. & Baruch, E. M. (2003). Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: Recommendations for management. American Journal of Drug and Alcohol Abuse, 29, 487-496.
35. Royo-Isaach, J., Magrane, M., Vila, R. & Capdevila, M. E. (2004). «Liquid ecstasy» (GHB) - a recreational drug? Bio-psychosocial clinical profile of the consumer and some therapeutic proposals. Atención Primaria, 33, 516-520.
36. Schneir, A. B., Ly, B. T. & Clark, R. F. (2001). A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol. Journal of Emergency Medicine, 21, 31-33. (Pubitemid 32496494)
37. Shannon, M. & Quang, L. S. (2000). Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: A case report and review of the literature. Pediatric Emergency Care, 16, 435-440.
38. Tarabar, A. F. & Nelson, L. S. (2004). The gamma-hydroxybutyrate withdrawal syndrome. Toxicology Review, 23, 45-49.
39. Trendelenburg, G. & Strohle, A. (2005). Gamma-hydroxybutyrate - a neurotransmitter, medicine, and drug. Nervenarzt, 76, 832, 834-838.
40. Weerts, E. M., Goodwin, A. K., Griffiths, R. R., Brown, P. R., Froestl, W., Jakobs, C. et al. (2005). Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology (Berl), 179, 678-687. (Pubitemid 40674770)
41. Wong, C. G., Gibson, K. M. & Snead, O. C. (2004a). From the street to the brain: Neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends in Pharmacological Sciences, 25, 29-34. (Pubitemid 38076954)
42. Wong, C. G., Chan, K. F., Gibson, K. M. & Snead, O. C. (2004b). Gamma-hydroxybutyric acid: Neurobiology and toxicology of a recreational drug. Toxicology Review, 23, 3-20. (Pubitemid 40484568)
43. Zepf, F. D., Holtmann, M., Duketis, E., Maier, J., Radeloff, D., Wagner, A. et al. (in press). A 16-year old boy with severe Gamma-Butyrolactone (GBL) withdrawal delirium - A case report. Pharmacopsychiatry.